Europe — EMA

Paclitaxel Stada

Paclitaxel, the active ingredient in Paclitaxel Stada, is a mitotic inhibitor presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Stada, is a mitotic inhibitor presented as a sterile injectable solution for intravenous use. It treats various malignant neoplasms and is administered in oncology settings.

GNH USA supplies Paclitaxel Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel is used in the treatment of solid tumours that follow - Breast Cancer: It holds … - Ovarian Cancer : - t d t \

What are the side effects of Paclitaxel?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →